Xylem Inc. $XYL Shares Sold by Parallel Advisors LLC

Parallel Advisors LLC trimmed its position in Xylem Inc. (NYSE:XYL) by 9.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,273 shares of the industrial products company’s stock after selling 4,391 shares during the quarter. Parallel Advisors LLC’s holdings in Xylem were worth $5,171,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of XYL. Commonwealth Retirement Investments LLC acquired a new stake in Xylem during the 4th quarter worth approximately $27,000. Wexford Capital LP purchased a new position in Xylem in the third quarter valued at approximately $27,000. Global Assets Advisory LLC acquired a new position in Xylem during the first quarter valued at approximately $40,000. FWL Investment Management LLC acquired a new position in Xylem during the second quarter valued at approximately $43,000. Finally, Entrust Financial LLC purchased a new stake in Xylem during the fourth quarter worth approximately $45,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on XYL. Oppenheimer dropped their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research report on Wednesday, April 29th. Royal Bank Of Canada upped their price target on shares of Xylem from $157.00 to $159.00 and gave the stock an “outperform” rating in a research report on Thursday. Weiss Ratings downgraded Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. CLSA raised Xylem to a “hold” rating in a research report on Thursday, June 25th. Finally, UBS Group boosted their price objective on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Xylem currently has a consensus rating of “Moderate Buy” and an average price target of $153.15.

Xylem Trading Down 1.6%

XYL opened at $120.82 on Tuesday. The firm has a market capitalization of $28.72 billion, a P/E ratio of 30.05, a P/E/G ratio of 1.75 and a beta of 1.03. The firm’s 50 day moving average is $113.40 and its 200-day moving average is $123.26. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.03. The business had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Analysts expect that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were given a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio is presently 42.79%.

Insider Activity

In other Xylem news, Director Jerome A. Peribere bought 1,210 shares of the stock in a transaction dated Monday, May 4th. The stock was bought at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the purchase, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at approximately $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.32% of the stock is owned by company insiders.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.